Victim Protection & Prevention

India approves first dengue vaccine amid rising cases in South Asia

1 min read
India approves first dengue vaccine amid rising cases in South Asia
Symbolic AI-generated illustration
This article was produced with AI assistance and editorially curated from public sources. The presumption of innocence applies until a final conviction.

Health authorities have warned for years that the threat posed by dengue is increasing worldwide, driven by climate change, urbanisation and growing international travel.

In South Asia, recent data show a clear rise in reported dengue cases, putting additional pressure on public health systems in the region.

In response to this situation, India has granted approval for its first dengue vaccine. The approval follows a thorough evaluation by Indian health authorities.

The vaccine is intended to help slow the spread of the disease and reduce the risk of severe illness.

Experts stress that vaccination must be complemented by mosquito control measures and public awareness campaigns to keep the risk at a low level.

Frequently asked questions

Why is the dengue vaccine being approved now?

Because of the rising case numbers in South Asia and the growing global threat posed by dengue.

What factors contribute to the spread of dengue?

Climate change, urbanisation and increased international travel are cited as the main drivers.

What does the approval mean for the region?

It provides a new preventive tool to help curb the rising dengue case numbers in South Asia.